OrthodonticsRMGICNCT06602154
Comparison of Bond Failure with Resin-modified Glass Ionomer Cement and Visible Light-cure Composite Bonding Material in Adult Orthodontic Patients - a Split-Mouth, Randomized Controlled Trial
A study testing Resin modified glass ionomer in people with Orthodontics and Bracket Bonding, run by Aga Khan University Hospital, Pakistan at 2 sites in Pakistan.
Trial summary
In this split mouth study design, 34 orthodontic patients coming for fixed appliance treatment will be bonded with standard light-cure composite bonding material and intervention of Resin Modified Glass Ionomer Cement (RMGIC). Read more about this study
- Who is it for?
- Ages 12 to 35 yearsHealthy volunteers can take part
- Conditions the study is for
- Orthodontics, Bracket Bonding, Malocclusion; Displaced or Missing Teeth
- What is being tested?
- Resin modified glass ionomer
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 37 participants
- Where
- 2 sitesPakistan
- Study dates
- 1 Nov 2021to 20 Feb 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 to 35 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- Patients aged between 12-35 years
- Patients with fair to good oral hygiene who have no significant sign of gingivitis
- Healthy patients with no co-morbids such as rheumatic fever, blood dyscrasias, congenital heart disease, or diabetes mellitus
- Patients with class I, II and III malocclusions
Who cannot join
- Enamel surface defects
- Pregnant patients or lactating mothers
- Syndromic patients
- Subjects with previous history of orthodontic
Trial locations and contacts
2 sites in 1 country.
Pakistan2 sites
Aga Khan University Hospital
Karachi, Sindh, 75500
Aga Khan University Hospital
Karachi
About this study
In this split mouth study design, 34 orthodontic patients coming for fixed appliance treatment will be bonded with standard light-cure composite bonding material and intervention of Resin Modified Glass Ionomer Cement (RMGIC). Contralateral quadrants will be allocated randomly for either RMGIC or visible light-cure composite bonding in both upper and lower jaw.
Quadrant 1: Randomly selected, contralateral upper and lower quadrants from central incisor to second premolar will be bonded with RMGIC bonding system.
Read more
Quadrant 2: Randomly selected, contralateral quadrants from central incisor to second premolar will be bonded with visible light-cure composite bonding material.
Allocation of diagonally opposite quadrants by either bonding system will be assigned randomly. Quadrants to be bonded with Resin-modified glass ionomer cement and light-cure composite bonding material will be switched from patient to patient to ensure randomization. This study is single blinded. The study investigators will not be blinded while the patient will be kept blinded.
On the first visit, a specially designed consent form will be signed by the participant.
Patient interaction for the purpose of study will only be for 1 hour duration while bonding of brackets. After six months amount and location of bond breakages will be evaluated from orthodontic record files.
This study will help us evaluate bond strength of RMGIC as compared to light cure composite. RMGIC can also be considered as the choice of material for bonding in high risk caries patients.
Read the detailed description
MATERIAL \& METHODS:
Study Design: Experimental study (Randomized Control Trial) Settings: Dental clinics, The Aga Khan University Hospital, Karachi (AKUH) Duration of Study: Patients will be recruited in this study for one and half hour. Chart analysis of these patients will then be done after six months of recruitment.
Sample Size:
Sample size was calculated with OpenEpi (version 3.01) sample size calculator using findings of Hegarty and Macfarlane14 who reported a bond failure percentage of 30% with light-cure adhesive and risk ratio of 2.6 (1.7, 3.9) for RMGIC as compared to resin based light cured composite. Keeping the above risk ratio at level of significance (α) 5% and power of study (1-β) 80%, at least 34 subjects were required for our study. The sample size will be inflated by 10% to account for sample attrition; therefore, a total of 37 subjects will be included in the study.
Sampling Technique: Non-probability consecutive sampling
Sample Selection:
Inclusion Criteria:
- Patients aged between 18-35 years
- Patients with fair to good oral hygiene who have no significant sign of gingivitis
- Healthy patients with no co-morbids such as rheumatic fever, blood dyscrasias, congenital heart disease, or diabetes mellitus
- Patients with class I, II and III malocclusions
- All patients who will sign the consent form
Exclusion Criteria:
- Enamel surface defects
- Pregnant patients or lactating mothers
- Syndromic patients
- Subjects with previous history of orthodontic or functional appliance treatment
DATA COLLECTION PROCEDURE:
Data will be collected by well-organized proforma. (Annexure H) Ethical approval will be taken from the institutional Ethical Review Committee (ERC) before commencement of the study. All those patients who sign an informed consent form (Annexure I) will receive detailed information regarding the study.
Due to ethical considerations, only patients requiring fixed appliance orthodontic treatment will be recruited. In this split mouth study design, contralateral quadrants will be allocated randomly for either Resin-modified glass ionomer cement or visible light-cure composite bonding in both upper and lower jaw. Randomization as per annerxure J Quadrant 1: Randomly selected, contralateral upper and lower quadrants from central incisor to second premolar will be bonded with RMGIC bonding system.
Quadrant 2: Randomly selected, contralateral quadrants from central incisor to second premolar will be bonded with visible light-cure composite.
On the first visit, a specially designed consent form will be signed by the participant. The investigator will unseal the envelope from Clinical Trials Unit (CTU), containing information regarding the participants based on randomization.
Ethical considerations:
Study will be carried out as per guidelines of World Medical Association's Declaration of Helsinki and principles of GCP (Good Clinical Practice). Any modifications in the protocol will be re-submitted to the ERC. The trial will be conducted in compliance with regulations and a copy of the final study protocol will be submitted to ERC.
Consent:
After assessment of eligibility criteria, participants will be included in this study after signing consent form. Consent form will be explained to patient in a separate dental room by investigators to ensure privacy. If patient will be unable to decide then consent form will be given to patient and asked to reply after decision in 7 days. One copy of consent will be given to patient after signing and one copy will be kept with the investigators.
- Being tested
- Resin modified glass ionomer
- Keywords
- Resin-modified glass ionomer cement, Light cure composite, bracket bonding
- Medical subject headings
- Malocclusion, Anodontia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Resin modified glass ionomerOther
The product will be stored by investigators at room temperature in lock and key.
Product: Riva light cure RMGIC (HV) Composition: 18 mg orthodontic bonding paste and 6 ml enamel bond resin. Storage: Stored at room temperature and protected from humidity.
Usage: Steps for Resin-modified glass ionomer cement composite bonding:
- Prepare all teeth with oil-free pumice, and rinse thoroughly for 15 seconds with water.
- Wash thoroughly.
- Etch enamel surface with 37% phosphoric acid for 15 seconds.
- Rinse the etched surface for 20 seconds to remove the acid and precipitates that might have formed during the etching procedure.
- Activate the capsule and immediately mix in an amalgamator. Do not click with applicator before you mix.
- Immediately place into capsule applicator and click trigger until paste is seen through the nozzle
- Light cure each increment for 20 seconds.
| Study group | Role | What they receive |
|---|---|---|
| Control group ( light cure composite ) | Active comparator | Product: Denturum Light Cure Band Adhesive (Ortho Organizers). Composition: 4 mg composite adhesive paste and 6 ml Transbond primer. Storage: Stored at room temperature and protected from humidity.
Usage: Steps for light -cure composite bonding are:
1. Prepare teeth with oil-free pumice, and rinse thoroughly for 15 seconds with water.
2. Air dry tooth surface for 5 seconds until dry field is maintained and isolate with cotton rolls.
3. Etch enamel surface with 37% phosphoric acid for 15 seconds.
4. Rinse the etched surface for 20 seconds to remove the acid and precipitates that might have formed during the etching procedure.
5. Thoroughly dry etched surface with moisture free air. Tooth surface should appear frosty white, if not than reetch for 5 seconds.
6. Brush thin uniform amount of primer on every tooth surface.
7. Apply a small amount of adhesive paste onto bracket base and position the bracket on tooth surface.
8. After accurately placing bracket on tooth surfac Receives: Other: Resin modified glass ionomer |
What is being measured
The primary outcome is the main question the study is designed to answer.
Bracket bond failure
The objective of this study is to compare rate of bond failures with Resin-modified glass ionomer cement and visible light-cure bonding.
Measured: Three months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2024
- Study start1 Nov 2021
- Primary completion20 Feb 2022
- Study completion20 Feb 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for OrthodonticsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 37 participants (actual)
Sponsor and investigators
- Lead sponsor
- Aga Khan University Hospital, Pakistan
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rashna Hoshang Sukhia, Aga Khan University Hospital, Pakistan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06602154
- Sponsor's protocol ID
- 2022-5282-23281
- Other IDs
- Dr. Aleem Saeed Qureshi
- Acronym
- RMGIC
- Status last verified
- Sep 2024
- First submitted
- 13 Sep 2024
- Last updated
- 19 Sep 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Qabool H, Qabool J, Sukhia RH, Fida M. Comparison of bond failure with resin-modified glass ionomer cement and visible light-cured composite bonding systems in orthodontic patients: A split-mouth randomized controlled trial. Dent Med Probl. 2024 Sep-Oct;61(5):651-657. doi: 10.17219/dmp/162970.
PubMed 39364623
Study at a glance
From the registry record, last updated by the sponsor on 19 Sep 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparison of Bond Failure with Resin-modified Glass Ionomer Cement and Visible Light-cure Composite Bonding Material in Adult Orthodontic Patients - a Split-Mouth, Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06602154
- Acronym / sponsor ID
- RMGIC / 2022-5282-23281
- Keywords
- Resin-modified glass ionomer cement, Light cure composite, bracket bonding
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 37 participants (actual)
- Lead sponsor
- Aga Khan University Hospital, PakistanUniversity, hospital or other
- Study start
- 1 Nov 2021 (actual)
- Primary completion
- 20 Feb 2022 (actual)
- Study completion
- 20 Feb 2022 (actual)
- First posted
- 19 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this split mouth study design, 34 orthodontic patients coming for fixed appliance treatment will be bonded with standard light-cure composite bonding material and intervention of Resin Modified Glass Ionomer Cement (RMGIC). Contralateral quadrants will be allocated randomly for either RMGIC or visible light-cure composite bonding in both upper and lower jaw.
Quadrant 1: Randomly selected, contralateral upper and lower quadrants from central incisor to second premolar will be bonded with RMGIC bonding system.
Quadrant 2: Randomly selected, contralateral quadrants from central incisor to second premolar will be bonded with visible light-cure composite bonding material.
Allocation of diagonally opposite quadrants by either bonding system will be assigned randomly. Quadrants to be bonded with Resin-modified glass ionomer cement and light-cure composite bonding material will be switched from patient to patient to ensure randomization. This study is single blinded. The study investigators will not be blinded while the patient will be kept blinded.
On the first visit, a specially designed consent form will be signed by the participant.
Patient interaction for the purpose of study will only be for 1 hour duration while bonding of brackets. After six months amount and location of bond breakages will be evaluated from orthodontic record files.
This study will help us evaluate bond strength of RMGIC as compared to light cure composite. RMGIC can also be considered as the choice of material for bonding in high risk caries patients.
Detailed description
MATERIAL \& METHODS:
Study Design: Experimental study (Randomized Control Trial) Settings: Dental clinics, The Aga Khan University Hospital, Karachi (AKUH) Duration of Study: Patients will be recruited in this study for one and half hour. Chart analysis of these patients will then be done after six months of recruitment.
Sample Size:
Sample size was calculated with OpenEpi (version 3.01) sample size calculator using findings of Hegarty and Macfarlane14 who reported a bond failure percentage of 30% with light-cure adhesive and risk ratio of 2.6 (1.7, 3.9) for RMGIC as compared to resin based light cured composite. Keeping the above risk ratio at level of significance (α) 5% and power of study (1-β) 80%, at least 34 subjects were required for our study. The sample size will be inflated by 10% to account for sample attrition; therefore, a total of 37 subjects will be included in the study.
Sampling Technique: Non-probability consecutive sampling
Sample Selection:
Inclusion Criteria:
- Patients aged between 18-35 years
- Patients with fair to good oral hygiene who have no significant sign of gingivitis
- Healthy patients with no co-morbids such as rheumatic fever, blood dyscrasias, congenital heart disease, or diabetes mellitus
- Patients with class I, II and III malocclusions
- All patients who will sign the consent form
Exclusion Criteria:
- Enamel surface defects
- Pregnant patients or lactating mothers
- Syndromic patients
- Subjects with previous history of orthodontic or functional appliance treatment
DATA COLLECTION PROCEDURE:
Data will be collected by well-organized proforma. (Annexure H) Ethical approval will be taken from the institutional Ethical Review Committee (ERC) before commencement of the study. All those patients who sign an informed consent form (Annexure I) will receive detailed information regarding the study.
Due to ethical considerations, only patients requiring fixed appliance orthodontic treatment will be recruited. In this split mouth study design, contralateral quadrants will be allocated randomly for either Resin-modified glass ionomer cement or visible light-cure composite bonding in both upper and lower jaw. Randomization as per annerxure J Quadrant 1: Randomly selected, contralateral upper and lower quadrants from central incisor to second premolar will be bonded with RMGIC bonding system.
Quadrant 2: Randomly selected, contralateral quadrants from central incisor to second premolar will be bonded with visible light-cure composite.
On the first visit, a specially designed consent form will be signed by the participant. The investigator will unseal the envelope from Clinical Trials Unit (CTU), containing information regarding the participants based on randomization.
Ethical considerations:
Study will be carried out as per guidelines of World Medical Association's Declaration of Helsinki and principles of GCP (Good Clinical Practice). Any modifications in the protocol will be re-submitted to the ERC. The trial will be conducted in compliance with regulations and a copy of the final study protocol will be submitted to ERC.
Consent:
After assessment of eligibility criteria, participants will be included in this study after signing consent form. Consent form will be explained to patient in a separate dental room by investigators to ensure privacy. If patient will be unable to decide then consent form will be given to patient and asked to reply after decision in 7 days. One copy of consent will be given to patient after signing and one copy will be kept with the investigators.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Control group ( light cure composite ) | Active comparator | Other: Resin modified glass ionomerProduct: Denturum Light Cure Band Adhesive (Ortho Organizers). Composition: 4 mg composite adhesive paste and 6 ml Transbond primer. Storage: Stored at room temperature and protected from humidity. Usage: Steps for light -cure composite bonding are: 1. Prepare teeth with oil-free pumice, and rinse thoroughly for 15 seconds with water. 2. Air dry tooth surface for 5 seconds until dry field is maintained and isolate with cotton rolls. 3. Etch enamel surface with 37% phosphoric acid for 15 seconds. 4. Rinse the etched surface for 20 seconds to remove the acid and precipitates that might have formed during the etching procedure. 5. Thoroughly dry etched surface with moisture free air. Tooth surface should appear frosty white, if not than reetch for 5 seconds. 6. Brush thin uniform amount of primer on every tooth surface. 7. Apply a small amount of adhesive paste onto bracket base and position the bracket on tooth surface. 8. After accurately placing bracket on tooth surfac |
Who may qualify
- Ages
- 12 to 35 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (4 listed)
- Patients aged between 12-35 years
- Patients with fair to good oral hygiene who have no significant sign of gingivitis
- Healthy patients with no co-morbids such as rheumatic fever, blood dyscrasias, congenital heart disease, or diabetes mellitus
- Patients with class I, II and III malocclusions
Key exclusion criteria (4 listed)
- Enamel surface defects
- Pregnant patients or lactating mothers
- Syndromic patients
- Subjects with previous history of orthodontic
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Resin modified glass ionomerThe product will be stored by investigators at room temperature in lock and key. Product: Riva light cure RMGIC (HV) Composition: 18 mg orthodontic bonding paste and 6 ml enamel bond resin. Storage: Stored at room temperature and protected from humidity. Usage: Steps for Resin-modified glass ionomer cement composite bonding: 1. Prepare all teeth with oil-free pumice, and rinse thoroughly for 15 seconds with water. 2. Wash thoroughly. 3. Etch enamel surface with 37% phosphoric acid for 15 seconds. 4. Rinse the etched surface for 20 seconds to remove the acid and precipitates that might have formed during the etching procedure. 5. Activate the capsule and immediately mix in an amalgamator. Do not click with applicator before you mix. 6. Immediately place into capsule applicator and click trigger until paste is seen through the nozzle 7. Light cure each increment for 20 seconds. | Other | Control group ( light cure composite ) |
Primary outcome
Bracket bond failure
Time frame: Three months
The objective of this study is to compare rate of bond failures with Resin-modified glass ionomer cement and visible light-cure bonding.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Sep 2024.
- Derived from this study: PubMed 39364623Qabool H, Qabool J, Sukhia RH, Fida M. Comparison of bond failure with resin-modified glass ionomer cement and visible light-cured composite bonding systems in orthodontic patients: A split-mouth randomized controlled trial. Dent Med Probl. 2024 Sep-Oct;61(5):651-657. doi: 10.17219/dmp/162970.
- Individual participant dataSharing planned: No
Related trials for Orthodontics
Active, not recruitingObservational study
Accuracy and Time Efficiency of AI Versus Manual Segmentation in Adult Crowding Using Aligner Software
Dental Crowding
Enrolling by invitation
Discision as Acceleration Method in Canine Retraction in Orthodontics With Aligner and Fixed Appliances in Young Adults a Split Mouth Study
Bimaxillary Protrusion, Class II Div 1 Malocclusion
Not yet recruiting
Manus AI-Assisted Orthodontic Education and Oral Health-Related Quality of Life
Oral Health-Related Quality of Life
Active, not recruiting
A Split-Mouth Clinical Trial Evaluating the Bond Failure Rate of a New Etch-Free Orthodontic Adhesive
Bracket Bonding, Orthodontic Treatment
Active, not recruiting
Treatment of the Mandibular Dental Crowding With and Without Corticotomy Surgery
Dental Research, Orthodontics
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Resin modified glass ionomer in people with Orthodontics and Bracket Bonding, run by Aga Khan University Hospital, Pakistan at 2 sites in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Bracket bond failure (time frame: Three months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06602154, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.